Alzamend NeuroALZN
13F holders, Q2 2026 (June 30)12holders −1
2new positions
3sold out
$1.20avg. 13F price*
At the end of Q2 2026, 12 institutions reported holding Alzamend Neuro Inc. (ALZN) in their 13F filings, down 1 from Q1 2026. 2 opened new positions and 3 sold out. The largest holders were Kingsbury Capital Investment Advisors LLC ($1.6M), KMT Wealth Management, LLC ($1.6M) and Geode Capital Management, LLC ($32K).
- Company
- Alzamend Neuro Inc.
- CUSIP
- 02262M605
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1.6M |
| Exits | 3 | $35K |
All 13F filers, Q1 2026 → Q2 2026: 2,094,645 shares bought and 57,360 shares sold, net +2,037,285 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Kingsbury Capital Investment Advisors LLC | 1.35% | Add +134.5% | 1,329,100 | $1.6M |
| KMT Wealth Management, LLC | 1.35% | New | 1,329,100 | $1.6M |
| Geode Capital Management, LLC | 0.00% | Reduce -42.3% | 26,371 | $32K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 21,020 | $25K |
| Vanguard Capital Management LLC | 0.00% | Add +71.7% | 7,556 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -43.1% | 3,517 | $4K |
| UBS Group AG | 0.00% | Reduce -47.8% | 2,352 | $3K |
| BlackRock, Inc. | 0.00% | No change | 437 | $524 |
| IFG Advisory, LLC | 0.00% | New | 22 | $26 |
| SBI Securities Co., Ltd. | 0.00% | No change | 22 | $26 |
| Caitong International Asset Management Co., Ltd | 0.00% | Reduce -25.0% | 3 | $4 |
| Harbor Investment Advisory, LLC | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is ALZN's weight in each manager's 13F, not the share of Alzamend Neuro Inc. the manager owns.